/ABRT.CN

ABRT.CN Stock - Albert Labs International Corp.

Q: What is the analyst price target for ABRT.CN?

Analyst price target information is not currently available for ABRT.CN.

Q: What is ABRT.CN's market cap?

Market capitalization information is not currently available for ABRT.CN.

Healthcare|Biotechnology|CNQ

$0.01+0.00%

+$0.00 (+0.00%) • Jul 15

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.01

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ABRT.CN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2019

FY2020

FY2021

FY2022

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.42

52W High$0.04

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021	FY2020	FY2019	FY2018
Revenue	N/A	N/A	N/A	N/A	$90,354
Gross Profit	$-3,422	$-2,014	N/A	N/A	$90,354
Gross Margin	N/A	N/A	N/A	N/A	100.0%
Operating Income	$-4,137,951	$-1,878,961	$-279,760	$-132,990	$-280,110
Net Income	$-7,058,813	$-1,878,961	$-284,025	$-135,025	$-280,107
Net Margin	N/A	N/A	N/A	N/A	-310.0%
EPS	$-0.13	$-0.47	$-0.04	$-0.02	$-0.04

Company Overview

Albert Labs International Corp. operates as a clinical research and drug development company. The company focuses on treating patients with urgent and unmet needs, including critical mental health indications. It develops psilocybin-assisted therapies to improve mental health conditions, including anxiety, depression, and oncology-related distress. The company is based in Burnaby, Canada.

Visit Website

Frequently Asked Questions about ABRT.CN

What is ABRT.CN's current stock price?

Albert Labs International Corp. (ABRT.CN) is currently trading at $0.01 per share. The stock has moved +0.00% today.

What is the analyst price target for ABRT.CN?

No analyst price targets are currently available for this stock.

What sector is Albert Labs International Corp. in?

Albert Labs International Corp. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the CNQ exchange.

What is ABRT.CN's market cap?

Albert Labs International Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does ABRT.CN pay dividends?

No, Albert Labs International Corp. does not currently pay a dividend to shareholders.